Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Comperat

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
BJU International|December 2, 2008
Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experienceEvanguelos Xylinas, Sarah J Drouin, Eva Comperat, et al.
Scientific Reports|July 28, 2022
Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penisBettina Trimmel, Andre Oszwald, Christoph Diemand, et al.
Radiology|April 13, 2013
Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter studyPhilippe Puech, Olivier Rouvière, Raphaele Renard-Penna, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|March 27, 2009
Mapping of transrectal ultrasonographic prostate biopsies: quality control and learning curve assessment by image processingPierre Mozer, Michael Baumann, Gregoire Chevreau, et al.
Nuclear Medicine and Biology|April 7, 2020
A comparative study of peptide-based imaging agents [<sup>68</sup>Ga]Ga-PSMA-11, [<sup>68</sup>Ga]Ga-AMBA, [<sup>68</sup>Ga]Ga-NODAGA-RGD and [<sup>68</sup>Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour modelsJules Zhang-Yin, Claire Provost, Géraldine Cancel-Tassin, et al.
Urologic Oncology|January 21, 2024
Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PETNicolai A Huebner, Gabriel Wasinger, Pawel Rajwa, et al.
Histopathology|November 17, 2018
Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cellsManuel L Gonzalez, Reza Alaghehbandan, Krystina Pivovarcikova, et al.
European Urology|October 24, 2012
A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimensDonna E Hansel, Mahul B Amin, Eva Comperat, et al.
Histopathology|February 8, 2023
Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small-cell carcinoma of the bladderVamsi Parimi, Woonyoung Choi, Mingxiao Feng, et al.
Histopathology|April 20, 2019
High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complexKiril Trpkov, Michael Bonert, Yuan Gao, et al.
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
BJU International|December 2, 2008
Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experienceEvanguelos Xylinas, Sarah J Drouin, Eva Comperat, et al.
Scientific Reports|July 28, 2022
Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penisBettina Trimmel, Andre Oszwald, Christoph Diemand, et al.
Radiology|April 13, 2013
Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter studyPhilippe Puech, Olivier Rouvière, Raphaele Renard-Penna, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|March 27, 2009
Mapping of transrectal ultrasonographic prostate biopsies: quality control and learning curve assessment by image processingPierre Mozer, Michael Baumann, Gregoire Chevreau, et al.
Nuclear Medicine and Biology|April 7, 2020
A comparative study of peptide-based imaging agents [<sup>68</sup>Ga]Ga-PSMA-11, [<sup>68</sup>Ga]Ga-AMBA, [<sup>68</sup>Ga]Ga-NODAGA-RGD and [<sup>68</sup>Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour modelsJules Zhang-Yin, Claire Provost, Géraldine Cancel-Tassin, et al.
Urologic Oncology|January 21, 2024
Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PETNicolai A Huebner, Gabriel Wasinger, Pawel Rajwa, et al.
Histopathology|November 17, 2018
Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cellsManuel L Gonzalez, Reza Alaghehbandan, Krystina Pivovarcikova, et al.
European Urology|October 24, 2012
A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimensDonna E Hansel, Mahul B Amin, Eva Comperat, et al.
Histopathology|February 8, 2023
Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small-cell carcinoma of the bladderVamsi Parimi, Woonyoung Choi, Mingxiao Feng, et al.
Histopathology|April 20, 2019
High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complexKiril Trpkov, Michael Bonert, Yuan Gao, et al.
Pageof 17